Diffuse Scleroderma clinical trials at UCSF

2 in progress, 1 open to eligible people

Showing trials for

  • Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis

    open to eligible people ages 18-65

    The purpose of this study is to evaluate the efficacy, safety and tolerability of rapcabtagene autoleucel (administered once following lymphodepletion) in participants with severe refractory diffuse cutaneous systemic sclerosis relative to rituximab.

    San Francisco, California and other locations

  • BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Sorry, in progress, not accepting new patients

    The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.

    San Francisco, California and other locations

Last updated: